These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1581459)

  • 1. [An update on the clinical and pathogenetic value of a lymphocyte subpopulation study in systemic lupus erythematosus].
    López-Gómez M; Sampalo Lainz A; Jiménez-Alonso J
    An Med Interna; 1992 Apr; 9(4):200-4. PubMed ID: 1581459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte subsets in systemic lupus erythematosus.
    Cheong SK; Chin SF; Kong NC
    Malays J Pathol; 1997 Dec; 19(2):121-5. PubMed ID: 10879252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
    Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
    Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of systemic lupus erythematosus.
    Francis L; Perl A
    Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity in systemic lupus erythematosus.
    Boumpas DT; Eleftheriades EG; Tsokos GC
    In Vivo; 1988; 2(1):41-5. PubMed ID: 2979815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
    Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
    J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress.
    Pawlak CR; Jacobs R; Mikeska E; Ochsmann S; Lombardi MS; Kavelaars A; Heijnen CJ; Schmidt RE; Schedlowski M
    Brain Behav Immun; 1999 Dec; 13(4):287-302. PubMed ID: 10600217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
    Otsuka T; Okamura S; Niho Y; Kusaba T
    J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
    Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
    Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of T and B lymphocytes in the pathogenesis of systemic lupus erythematosus].
    Gliński W
    Przegl Dermatol; 1976; 63(4):505-12. PubMed ID: 788057
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
    Messner RP; Lindström FD; Williams RC
    J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
    Humbert M; Galanaud P
    Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.